MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0042050
Arznei-Alfa Pharma Private Limited
Arznei-Alfa Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.12 Lakh
▼ 52% YoY
Net loss · FY 2025
₹23,330
Net margin -1.9%
EBITDA · FY 2025
-₹23,330
EBITDA margin -1.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Arznei-Alfa Pharma Private Limited
Data last updated:
Arznei-Alfa Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC316831. Its GSTIN is 27AARCA5482A1ZL (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Chandra (Whole-Time Director) and Amreen Prashant Chandra (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 9 002 Poonam Sagar Complex Mira Bhayander Mira Road East, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.12 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹23,330 (net margin -1.9%) and EBITDA of -₹23,330 (EBITDA margin -1.9%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 26% over five years.
Arznei-Alfa Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0042050). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2018PTC316831
Registration Number 316831
Incorporation Date 05 November 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0042050
Recognitions & Rankings of Arznei-Alfa Pharma
Contact details
Arznei-Alfa Pharma Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressE – 9 002 Poonam Sagar Complex Mira Bhayander Mira Road East, Thane, Maharashtra, India – 401107
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Arznei-Alfa Pharma Private Limited, buy the company report.
Comprehensive company report
Arznei-Alfa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Arznei-Alfa Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Arznei-Alfa Pharma Private Limited, buy the company report.
Financials of Arznei-Alfa Pharma Private Limited
FY 2025 filings availableArznei-Alfa Pharma Private Limited reported revenue of ₹12.12 Lakh (down 52% YoY) for FY 2025.
Revenue · FY 2025
₹12.12 Lakh ▼ 52%
Net loss · FY 2025
₹23,330 margin -1.9%
EBITDA · FY 2025
-₹23,330 margin -1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 52%
3 years · compounded
▼ 65%
5 years · compounded
▼ 26%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▼ 32%
5 years · compounded
▼ 22%
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 52% fall in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹23,330 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23,330 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.9% | ||||
| Net Profit Margin | -1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arznei-Alfa Pharma Private Limited, buy the company report.
Board of directors of Arznei-Alfa Pharma Private Limited
Arznei-Alfa Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Chandra | Whole-Time Director | 05 Nov 2018 | 7 Years 11 Months | Current |
| Amreen Prashant Chandra | Whole-Time Director | 05 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Arznei-Alfa Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accessible Home Health Care Private Limited | ₹12.36 Lakh (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Utsuk Kadam Foundation | ₹12.23 Lakh (FY 2025) | 149.0% | Delhi, India | |||
| Shay Dermacos Private Limited | ₹12.16 Lakh (FY 2025) | -21.0% | New Delhi, Delhi, India | |||
| RX Remedial Surgical Private Limited | ₹12.15 Lakh (FY 2025) | -46.0% | New Delhi, Delhi, India | |||
| Craveon Healthcare Private Limited | ₹12.13 Lakh (FY 2022) | Bhopal, Madhya Pradesh, India | ||||
| Arznei-Alfa Pharma Private Limitedthis company | ₹12.12 Lakh (FY 2025) | -₹23,330 | -1.9% | -52.0% | Thane, Maharashtra, India | |
| Cureline Healthcare Private Limited | ₹12.12 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Solapur Pet CT Scans Private Limited | ₹12.1 Lakh (FY 2025) | Solapur, Maharashtra, India | ||||
| Remedica Healthcare Solutions Private Limited | ₹12.06 Lakh (FY 2024) | 3566.0% | Pune, Maharashtra, India | |||
| Soul Inside Foundation | ₹12.05 Lakh (FY 2025) | -48.0% | Naveen Nagar, Uttar Pradesh, India | |||
| SRNR Health Care Private Limited | ₹12.02 Lakh (FY 2025) | -61.0% | Jhunjhunu, Rajasthan, India |
To see the full peer comparison of Arznei-Alfa Pharma Private Limited, buy the company report.
Auditor
Arznei-Alfa Pharma Private Limited is audited by RAHUL H JAIN & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL H JAIN & CO | FY 2021 | 132203W |
Shareholding
The shareholding of Arznei-Alfa Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Arznei-Alfa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arznei-Alfa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arznei-Alfa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arznei-Alfa Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA5482A1ZL | Maharashtra | Active | 14 Jan 2019 |
To see the full GST registrations and return filing status of Arznei-Alfa Pharma Private Limited, buy the company report.
Recent activity
Arznei-Alfa Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Amreen Prashant Chandra was appointed as Whole-Time Director on 05 Nov 2018.
AGM
Arznei-Alfa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arznei-Alfa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Amreen Prashant Chandra was appointed as Whole-Time Director.
Appointed
Prashant Chandra was appointed as Whole-Time Director.
Incorporation
05 Nov 2018
Arznei-Alfa Pharma Private Limited was registered on 05 Nov 2018 with Roc Mumbai Ii & aged 7 years 11 months as per MCA records.
Frequently asked questions
Arznei-Alfa Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 November 2018 (8+ years old) and is registered under CIN U74999MH2018PTC316831.
Arznei-Alfa Pharma has 2 current directors:
- Prashant Chandra - Whole-Time Director
- Amreen Prashant Chandra - Whole-Time Director
The latest financial statements of Arznei-Alfa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Arznei-Alfa Pharma is 27AARCA5482A1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Arznei-Alfa Pharma is U74999MH2018PTC316831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arznei-Alfa Pharma was incorporated on 05 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arznei-Alfa Pharma by revenue are Accessible Home Health Care Private Limited, Utsuk Kadam Foundation, Shay Dermacos Private Limited, RX Remedial Surgical Private Limited, Craveon Healthcare Private Limited and 5 more, all in the same principal business activity (human health activities).
Amreen Prashant Chandra was appointed as Whole-Time Director on 05 Nov 2018. Prashant Chandra was appointed as Whole-Time Director on 05 Nov 2018.
Yes, Arznei-Alfa Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0042050).
The registered office of Arznei-Alfa Pharma is at E – 9 002 Poonam Sagar Complex Mira Bhayander Mira Road East, Thane, Maharashtra, India – 401107.
Arznei-Alfa Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages